| The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells SU Mertens-Talcott, S Chintharlapalli, X Li, S Safe Cancer research 67 (22), 11001-11011, 2007 | 572 | 2007 |
| Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma PR Galle, F Foerster, M Kudo, SL Chan, JM Llovet, S Qin, WR Schelman, ... Liver international 39 (12), 2214-2229, 2019 | 422 | 2019 |
| Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors S Chintharlapalli, S Papineni, SK Ramaiah, S Safe Cancer research 67 (6), 2816-2823, 2007 | 370 | 2007 |
| Cancer chemotherapy with indole-3-carbinol, bis (3′-indolyl) methane and synthetic analogs S Safe, S Papineni, S Chintharlapalli Cancer letters 269 (2), 326-338, 2008 | 316 | 2008 |
| Anthocyanin fraction from potato extracts is cytotoxic to prostate cancer cells through activation of caspase-dependent and caspase-independent pathways L Reddivari, J Vanamala, S Chintharlapalli, SH Safe, JC Miller Jr Carcinogenesis 28 (10), 2227-2235, 2007 | 248 | 2007 |
| Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy D Gerald, S Chintharlapalli, HG Augustin, LE Benjamin Cancer research 73 (6), 1649-1657, 2013 | 230 | 2013 |
| Curcumin decreases specificity protein expression in bladder cancer cells G Chadalapaka, I Jutooru, S Chintharlapalli, S Papineni, R Smith III, X Li, ... Cancer research 68 (13), 5345-5354, 2008 | 218 | 2008 |
| Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and-independent downregulation of specificity proteins (Sp) transcription factors S Chintharlapalli, S Papineni, P Lei, S Pathi, S Safe BMC cancer 11, 1-12, 2011 | 199 | 2011 |
| Activation of Nur77 by selected 1, 1-Bis (3′-indolyl)-1-(p-substituted phenyl) methanes induces apoptosis through nuclear pathways S Chintharlapalli, R Burghardt, S Papineni, S Ramaiah, K Yoon, S Safe Journal of biological chemistry 280 (26), 24903-24914, 2005 | 189 | 2005 |
| Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor–dependent and nuclear receptor–independent pathways SD Cho, K Yoon, S Chintharlapalli, M Abdelrahim, P Lei, S Hamilton, ... Cancer research 67 (2), 674-683, 2007 | 187 | 2007 |
| Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth SO Lee, M Abdelrahim, K Yoon, S Chintharlapalli, S Papineni, K Kim, ... Cancer research 70 (17), 6824-6836, 2010 | 170 | 2010 |
| GDF15 and growth control PJ Emmerson, KL Duffin, S Chintharlapalli, X Wu Frontiers in physiology 9, 1712, 2018 | 158 | 2018 |
| 1,1-Bis(3′-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth T Inamoto, S Papineni, S Chintharlapalli, SD Cho, S Safe, AM Kamat Molecular cancer therapeutics 7 (12), 3825-3833, 2008 | 152 | 2008 |
| Oncogenic microRNA‐27a is a target for anticancer agent methyl 2‐cyano‐3, 11‐dioxo‐18β‐olean‐1, 12‐dien‐30‐oate in colon cancer cells S Chintharlapalli, S Papineni, M Abdelrahim, A Abudayyeh, I Jutooru, ... International journal of cancer 125 (8), 1965-1974, 2009 | 147 | 2009 |
| Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents BL Falcon, S Chintharlapalli, MT Uhlik, B Pytowski Pharmacology & therapeutics 164, 204-225, 2016 | 134 | 2016 |
| 1, 1-Bis (3′-indolyl)-1-(p-substitutedphenyl) methanes are peroxisome proliferator-activated receptor γ agonists but decrease HCT-116 colon cancer cell survival through … S Chintharlapalli, S Papineni, SJ Baek, S Liu, S Safe Molecular pharmacology 68 (6), 1782-1792, 2005 | 112 | 2005 |
| Inhibition of bladder tumor growth by 1, 1-bis (3′-indolyl)-1-(p-substitutedphenyl) methanes: a new class of peroxisome proliferator-activated receptor γ agonists W Kassouf, S Chintharlapalli, M Abdelrahim, G Nelkin, S Safe, AM Kamat Cancer research 66 (1), 412-418, 2006 | 110 | 2006 |
| 2-Cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor γ-dependent and … S Chintharlapalli, S Papineni, M Konopleva, M Andreef, I Samudio, S Safe Molecular pharmacology 68 (1), 119-128, 2005 | 105 | 2005 |
| Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator–activated receptor γ agonists in colon cancer cells S Chintharlapalli, S Papineni, I Jutooru, A McAlees, S Safe Molecular Cancer Therapeutics 6 (5), 1588-1598, 2007 | 101 | 2007 |
| Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met S Papineni, S Chintharlapalli, M Abdelrahim, S Lee, R Burghardt, ... Carcinogenesis 30 (7), 1193-1201, 2009 | 100 | 2009 |
